TIR Signalling Pathway Pharmacogenomics and Opioid Response: beyond the mu opioid receptor [ 2011 - 2013 ]

Also known as: Pain and Opioid Genetics

Research Grant

[Cite as]

Researchers: Prof Andrew Somogyi (Principal investigator)

Brief description This project will identify why some people respond poorly and others have toxic side effects to the major group of pain relieving medications, the opioids. The basis will be the genetics of the immune system and both acute postoperative and chronic cancer pain patients will be studied in this international pharmacogenetics project.

Funding Amount $AUD 246,396.72

Funding Scheme Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]